Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial 2025-12-12 04:49
FDA Lifts Clinical Hold on NUZ-001 2025-10-06 14:06
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 2025-07-03 07:09
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease 2025-06-16 19:00
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 2024-11-19 20:30
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe 2024-11-11 20:30
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
1